MedTrace Logo

Dilapan-S® for Induction of Labor The Feasibility Study

NCT04521062 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2023-04-18

No results posted yet for this study

Summary

This is a prospective feasibility study to investigate Dilapan-S® as an outpatient method of cervical ripening in low risk pregnancies \>=39 weeks.

Conditions

  • Induction of Labor Affected Fetus / Newborn

Interventions

DEVICE

Dilapan S

Placement of Dilapan S

Sponsors & Collaborators

  • Albany Medical College

    lead OTHER

Principal Investigators

  • Tara Lynch, MD · Albany Medical College

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2022-12-31
Completion
2022-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04521062 on ClinicalTrials.gov